EMA Authorised: Zurzuvae (zuranolone) — Biogen Netherlands B.V.

View source ↗

Summary

The EMA authorised Zurzuvae (zuranolone) by Biogen Netherlands B.V. for depression and postpartum depression.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Postpartum Depression

Drugs mentioned

• ZURZUVAE (ZURANOLONE)

Snippet

Status: Authorised. Therapeutic area: Depression, Postpartum. MAH: Biogen Netherlands B.V.. Decision date: 30/10/2025